Therefore, the inhibition and regulation of IL-6/JAK2/STAT3 signaling pathway is conducive to the prevention and treatment of tumors and the improvement of prognosis, and it is also one of the important targets for screening anti-tumor drugs (34). Here, STAT3 is linked to neoplasm.